DE69810460T2 - Östrogene 19-norandrost-17-on-derivate mit einem aromatischen b-ring - Google Patents

Östrogene 19-norandrost-17-on-derivate mit einem aromatischen b-ring

Info

Publication number
DE69810460T2
DE69810460T2 DE69810460T DE69810460T DE69810460T2 DE 69810460 T2 DE69810460 T2 DE 69810460T2 DE 69810460 T DE69810460 T DE 69810460T DE 69810460 T DE69810460 T DE 69810460T DE 69810460 T2 DE69810460 T2 DE 69810460T2
Authority
DE
Germany
Prior art keywords
ostrogenic
norandrost
aromatic
derivatives
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69810460T
Other languages
English (en)
Other versions
DE69810460D1 (de
Inventor
Muzafar Shah
Panolil Raveendranath
Z Kagan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth LLC filed Critical Wyeth LLC
Publication of DE69810460D1 publication Critical patent/DE69810460D1/de
Application granted granted Critical
Publication of DE69810460T2 publication Critical patent/DE69810460T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J17/005—Glycosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69810460T 1997-05-02 1998-04-28 Östrogene 19-norandrost-17-on-derivate mit einem aromatischen b-ring Expired - Fee Related DE69810460T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85042797A 1997-05-02 1997-05-02
PCT/US1998/008455 WO1998050412A1 (en) 1997-05-02 1998-04-28 Estrogenic 19-noradnrost-17-one derivatives with an aromatic b-ring

Publications (2)

Publication Number Publication Date
DE69810460D1 DE69810460D1 (de) 2003-02-06
DE69810460T2 true DE69810460T2 (de) 2003-10-02

Family

ID=25308082

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69810460T Expired - Fee Related DE69810460T2 (de) 1997-05-02 1998-04-28 Östrogene 19-norandrost-17-on-derivate mit einem aromatischen b-ring

Country Status (16)

Country Link
EP (1) EP0980382B1 (de)
JP (1) JP2001525806A (de)
KR (1) KR20010012155A (de)
CN (1) CN1254344A (de)
AR (1) AR012639A1 (de)
AT (1) ATE230412T1 (de)
AU (1) AU755007B2 (de)
BR (1) BR9809436A (de)
CA (1) CA2288999A1 (de)
DE (1) DE69810460T2 (de)
DK (1) DK0980382T3 (de)
ES (1) ES2187962T3 (de)
HK (1) HK1025776A1 (de)
PT (1) PT980382E (de)
WO (1) WO1998050412A1 (de)
ZA (1) ZA983688B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104557489B (zh) * 2014-11-22 2016-06-29 太原理工大学 一种3-环戊基丙醛的合成方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB864231A (en) * 1958-08-07 1961-03-29 Glaxo Lab Ltd Improvements in or relating to the preparation of steroids

Also Published As

Publication number Publication date
WO1998050412A1 (en) 1998-11-12
ZA983688B (en) 1999-11-01
AU755007B2 (en) 2002-11-28
EP0980382A1 (de) 2000-02-23
KR20010012155A (ko) 2001-02-15
JP2001525806A (ja) 2001-12-11
DE69810460D1 (de) 2003-02-06
DK0980382T3 (da) 2003-04-14
AU7164698A (en) 1998-11-27
AR012639A1 (es) 2000-11-08
EP0980382B1 (de) 2003-01-02
CA2288999A1 (en) 1998-11-12
PT980382E (pt) 2003-03-31
CN1254344A (zh) 2000-05-24
BR9809436A (pt) 2000-06-13
HK1025776A1 (en) 2000-11-24
ATE230412T1 (de) 2003-01-15
ES2187962T3 (es) 2003-06-16

Similar Documents

Publication Publication Date Title
DE69826286D1 (de) Derivate mit einem aromatischen ring
ATE260243T1 (de) N-aroylphenylalaninderivate
ATE235220T1 (de) Resorcinderivate
ID22781A (id) Turunan-turunan nikotinamida
DK0901474T3 (da) Arylpyrimidinderivater
DE69827870D1 (de) Drebohrmeissel mit beweglichen Formation-eingreifenden Elementen
ATE261942T1 (de) 6-phenylpyridinderivate
DE69817186D1 (de) Diaminorhodamin-derivate
IS1902B (is) Nýjar 19-nor-pregnene afleiður
NO981946D0 (no) Imidazoquinazolin-derivater
ATE255098T1 (de) Substituierte chromanderivate
DE69732576D1 (de) Tetrahydrobenzindolon-derivate
NO20000057D0 (no) Kjerneroer
ATE255099T1 (de) Substituierte chromanderivate
ATE440854T1 (de) 5-deoxy-cytidin-derivate
DE69808366D1 (de) Dimmer
EE9900182A (et) 2-metoksüfenüülpiperasiini derivaadid
DE69829682D1 (de) Cis-disubstituierte aminocycloalkyl-pyrrolidin-derivate
DE69828780D1 (de) Amidinocamptpthecin-derivate
NO981495D0 (no) Phenoxymetylpiperidin-derivater
DK0966437T3 (da) 5-Aroylnaphthalenderivater
DE69810460T2 (de) Östrogene 19-norandrost-17-on-derivate mit einem aromatischen b-ring
DK1015447T3 (da) Piperidinylmethyloxazolidinonderivat
FR2758526B1 (fr) Cerf-volant
DE69802830D1 (de) Aromatische substituierte naphtopyranen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee